Prescrizione di antiacidi, anti-H2 e IPP
nei primi tre anni di vita nella Regione Piemonte
1Dipartimento di Scienze della SanitÓ Pubblica e Pediatriche, UniversitÓ di Torino
2Pediatra di libera scelta, ASL TO4, Chivasso, Torino
Prescription of antiacid, ant-H2 and PPI in the first three years of life in the Piedmont Region
Gastroesophageal reflux disease (GERD), Antiacid, Anti-H2, Prescription,
Proton Pump Inhibitors (PPI)
Background - Despite the dissemination of guidelines and recommendations the treatment
of gastroesophageal reflux (GER) in the paediatric population is continuously increasing.
In Italy the phenomenon is still poorly documented.
Objective - Aim of this paper is to describe the occurrence and the frequency distribution
of the prescription of antiacids, anti-H2 and PPI in the 0 and 36 months infant population
in the Piedmont Region.
Materials and methods - All ATC A02 prescriptions archived in the regional pharmaceutical
data system assigned to a 0 to 3 years child in the period 2011-2013 were recovered.
All prescriptions were grouped into three main pharmacological categories: antiacids, anti-
H2 and PPI. Overall prescription, age and year specific rates were calculated.
Results - A total of 18,523 prescriptions of approximately 60 treatments per thousand
children were retrieved. The prescription rates were respectively in the three age 75.8 vs
12.7 and 10.5 prescriptions per thousand children in 2011; 68.5, 11.5 and 9.0 in 2012
and 61.7, 10.9 and 9.3 in 2013. Children aged 0-1 years were exposed to treatment 6/7
times more than those aged 1 to 2 and 2 to 3 years of age. The majority of these children
(70% vs 53% and 61% in the three age groups) had only one prescription in the course
of the year. The antiacid and anti-H2 were the most prescribed drugs, the observed trend
in the studied period is slightly lowering.
Conclusions - One child out of 14 new-borns is being treated for GERD in the Piedmont Region.
This high rate of prescriptions in the first year of life reinforces the already known:
GER in infants is physiological and resolves spontaneously, for this reason its treatment is
incongruous. To deal with the observed phenomenon multiple initiatives are needed, starting
from the legislative down to the clinical level. It is also of utmost importance to consolidate
a robust interregional surveillance system.
Vuoi citare questo contributo?
A. Borraccino, A. Ravaglia. PRESCRIZIONE DI ANTIACIDI, ANTI-H2 E IPP
NEI PRIMI TRE ANNI DI VITA NELLA REGIONE PIEMONTE.
Medico e Bambino 2014;33:647-651
L'accesso Ŕ riservato agli abbonati
alla rivista che si siano registrati
Per accedere all'articolo in formato full text
Ŕ necessario inserire username
La riproduzione senza autorizzazione è vietata. Le informazioni di tipo sanitario
contenute in questo sito Web sono rivolte a personale medico specializzato e non possono
in alcun modo intendersi come riferite al singolo e sostitutive dell'atto medico. Per
i casi personali si invita sempre a consultare il proprio medico curante. I contenuti
di queste pagine sono soggetti a verifica continua; tuttavia sono sempre possibili
errori e/o omissioni. Medico e Bambino non è
responsabile degli effetti derivanti dall'uso di queste informazioni.
Unauthorised copies are strictly forbidden. The medical information contained in the present web site is only addressed to specialized medical staff and cannot substitute any medical action. For personal cases we invite to consult one's GP. The contents of the pages are subject to continuous verifications; anyhow mistakes and/or omissions are always possible. Medico e Bambino is not liable for the effects deriving from an improper use of the information.